UNSPSC 51286208: Fosmidomycin

This classification denotes an antibiotic with the molecular formula C4H10NO5P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5829E3D9I9, chemically known as (3-(formylhydroxyamino)propyl)phosphonic acid, monosodium salt but more generally known as fosmidomycin, which bears US NIH Compound Identifier 572. European Medicines Agency schedules Fosmidomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07802MIG. The term FOSMIDOMYCIN is an International Non-Proprietary Name.

FOSMIDOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: P(=O)(O)(O)CCCN(O)C=O.

UNSPSC 51286208 Fosmidomycin is a Commodity code that nominally addresses a specific pharmaceutical product, but recent state and local procurement activity under this code does not reflect fosmidomycin procurement; instead, the code appears in solicitations for a broader range of pharmaceutical and medical supplies, including naloxone, generic multi-source pharmaceuticals, over-the-counter products, and emergency medical consumables. State and local governments buying under this code include county health departments, state pharmacy benefit programs, municipal fire departments, and multi-state cooperative purchasing alliances. The issuing bodies span Florida counties (Seminole County), Texas state agencies (Health and Human Services Commission), municipal purchasing offices (City of Tampa), and regional cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). Representative recent work includes Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building; the City of Tampa's sheltered-market IFB for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000 and a 5% bid discount for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities.

Activity under this code clusters in the Southeast (Florida) and upper Midwest (Minnesota serving multiple states including Oregon), with Texas state-level procurement also present. The Seminole County opportunity closed July 26, 2023 (IFB 60459723LAS), the City of Tampa opportunity closed March 13, 2026 (IFB 26P00145), and the Minnesota Multistate Cooperative Purchasing Alliance RFP closed March 26, 2026 (S1070000015802). The Texas HHS Commission issued an exploratory RFI on April 3, 2026 (HHS0017013) to gather vendor capabilities for a potential direct-to-manufacturer prescription program rather than to solicit competitive bids. The mismatch between the code's nominal scope (fosmidomycin) and the actual procurement activity suggests either a tagging error in the underlying data or that the code is being used as a catch-all for pharmaceutical procurement; the represented opportunities reflect genuine state and local demand for pharmaceutical supply contracting, but verification of the code's correct application to fosmidomycin specifically would be prudent before pursuing opportunities tagged under it.